SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is facing intense market volatility following a record-breaking earnings report that featured a triple beat and raised guidance, yet the stock remains under pressure as investors debate the company's valuation as a bank versus a fintech firm. The community is sharply divided, with bulls actively buying the dip based on strong fundamentals and growth metrics, while vocal bears express frustration over share dilution and the stock's persistent inability to sustain price gains post-earnings.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is currently a focal point for investors as it approaches earnings, with market participants intensely debating its role in powering AI data centers against broader concerns over volatility and institutional sell-offs. While many in the community view the stock as a critical infrastructure play for the AI supercycle, others remain cautious, citing significant price swings and speculative short-selling activity.

Vertiv Holdings Co. engages in the design, manufacture, and service of critical digital infrastructure technology for data centers, communication networks, and commercial and industrial environments. The firm also offers power management products, switchgear and busbar products, thermal management products, integrated rack systems, modular solutions, and management systems for monitoring and controlling digital infrastructure. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa (EMEA). The Americas segment includes products and services sold for applications within the data center, communication networks and commercial and industrial markets in North America and Latin America. The Asia Pacific segment consists of products and services sold for applications within the data center, communication networks and commercial and industrial markets throughout Greater China, Asia, and India. The EMEA segment focuses on products and services sold for applications within the data center, communication networks, and commercial and industrial markets in Europe, Middle East, and Africa. The company was founded in 1946 and is headquartered in Westerville, OH.

Vertiv Holdings Co - Ordinary Shares - Class A

Vertiv Holdings Co

Vertiv Holdings (VRT) is experiencing significant volatility as investors weigh the company's long-term dominance in AI-essential cooling and power infrastructure against concerns over its elevated valuation and recent profit-taking. Despite these short-term price swings and broader market jitters, the community remains heavily focused on the company's massive order backlog and its critical role in supporting the scaling of high-density AI data centers.

Ford Motor Co. engages in the manufacture, distribution, and sale of automobiles. It operates through the following segments: Ford Blue, Ford Model E, Ford Pro, Ford Credit, and Corporate Other. The Ford Blue, Ford Model E, and Ford Pro segment includes the sale of Ford and Lincoln vehicles, service parts, and accessories, together with the associated costs to develop, manufacture, distribute, and service the vehicles, parts, and accessories. The Ford Credit segment consists of the Ford Credit business on a consolidated basis, which is primarily vehicle-related financing and leasing activities. The Corporate Other segment refers to corporate governance expenses, past service pension and OPEB income and expense, interest income and gains and losses from cash, cash equivalents, and marketable securities, and foreign exchange derivatives gains, and losses associated with intercompany lending. The company was founded by Henry Ford on June 16, 1903 and is headquartered in Dearborn, MI.

Ford Motor Co.

Ford Motor Co

Ford is trending due to a positive shift in market sentiment following a strong earnings report that featured an earnings beat, raised full-year guidance, and a Citi upgrade. Investors are actively debating the company's profitability in the EV segment versus its traditional truck business, while also monitoring strategic moves like the company's expansion into energy storage and grid-scale battery solutions.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk Corp is seeing extreme volatility as sentiment shifts rapidly amid broader semiconductor sector pressure, driven by concerns over global chip supply dynamics and aggressive liquidation in international markets. Community discourse is highly polarized, with many investors debating whether this price action represents a forced deleveraging event or a structural shift in the demand outlook for memory stocks.

Lemonade, Inc. is a holding company, which engages in the provision of insurance services. The firm's products include renters and homeowners insurance, and pet insurance. It offers insurance coverage under the homeowners multi-peril, inland marine, and general liability lines of business. The company was founded by Daniel Asher Schreiber and Shai Wininger on June 17, 2015 and is headquartered in New York, NY.

Lemonade Inc

Lemonade Inc. shares are experiencing significant volatility following their recent earnings report, where strong revenue growth and improved loss ratios were overshadowed by a broader market pullback and investor caution regarding the timeline for profitability. While the community remains divided between those viewing the post-earnings dip as a long-term accumulation opportunity and those concerned about the company's path to sustained earnings, active discussions are focused on the stock's support levels and the potential for a recovery as management works toward its profitability targets.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

United States Oil Fund is experiencing extreme volatility as traders weigh the impact of renewed geopolitical tensions in the Strait of Hormuz against rumors of potential de-escalation efforts. The community is actively debating whether price swings are driven by genuine supply chain disruptions or speculative manipulation by algorithmic traders reacting to conflicting headlines about ceasefire talks.

Verra Mobility Corp. engages in the provision of smart mobility technology solutions. It operates through the following segments: Government Solutions, Commercial Services, and Parking Solutions. The Government Solutions segment offers automated safety solutions to state and local governments. The Commercial Services segment provides toll and violation management solutions by partnering with the fleet management and rental car companies. The Parking Solutions segment includes a suite of parking software and hardware solutions. The company was founded in 2004 and is headquartered in Mesa, AZ.

Verra Mobility Corp - Ordinary Shares - Class A

Verra Mobility is currently trending as investors debate whether the recent 70% sell-off following the loss of a major Avis contract is an extreme market overreaction given the company's remaining profitability and strong cash flow. The community is actively discussing the potential for a recovery, with bulls citing low valuation multiples and new government contracts as catalysts for a rebound, while bears remain concerned about long-term EBITDA impacts and the search for new leadership.

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Boston Scientific Corp.

Boston Scientific is currently trending as investors grapple with a significant share price decline, driven by concerns over slowing procedure volumes and revised growth guidance. The community remains deeply divided, with some investors viewing the pullback as a compelling long-term buying opportunity in a fundamental leader, while others express frustration over the lack of communication from management and the stock's persistent downward momentum.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarin (AMRN) is trending due to anticipation surrounding upcoming Q2 2026 earnings and potential legal updates from the Supreme Court, with the community actively debating whether current volume trends and cost-cutting measures signal an impending buyout or a long-term turnaround. Investors are closely monitoring management's commentary on global market growth and the potential for a new product formulation to stabilize the company's valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced that on July 10, 2026, the Compensation Committee of Mirums Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 6,300 shares of common stock and 9,300...

INCY Stock Hits 52-Week High on Regulatory Updates for Opzelura

Incyte shares hit a 52-week high as Opzelura gains regulatory momentum, pipeline advances and a CMS settlement boosts investor sentiment.

Strength Seen in Mirum Pharmaceuticals (MIRM): Can Its 5.5% Jump Turn into More Strength?

Mirum Pharmaceuticals (MIRM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Is Mirum Pharmaceuticals, Inc. (MIRM) Emerging as a Rare Disease Growth Story After New FOP Data?

Is Mirum Pharmaceuticals, Inc. (MIRM) Emerging as a Rare Disease Growth Story After New FOP Data...

MIRM, INCY Report Positive Rare Disease Data as FDA Begins NDA Review (Revised)

Mirum and Incyte's zilurgisertib cut new bone lesion formation in rare disease FOP, as the FDA begins Priority Review of the NDA with a Sept. 26, 2026, decision date.

MIRM, INCY Report Positive Rare Disease Data as FDA Begins NDA Review

Mirum Pharmaceuticals and Incyte Announce Positive Pivotal Phase 2 Results from PROGRESS Study of Zilurgisertib in Fibrodysplasia Ossificans Progressiva

Mirum Pharmaceuticals, Inc. (Nasdaq:MIRM) and Incyte (Nasdaq:INCY) today announced pivotal Phase 2 results from Cohort 1 of the PROGRESS study evaluating zilurgisertib, an investigational oral activin receptor-like kinase 2 (ALK2) inhibitor, in adolescents and adults (12 years of age) with...

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced that on June 10, 2026, the Compensation Committee of Mirums Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 10,100 shares of common stock and 13,350...

Why Is Mirum Pharmaceuticals (MIRM) Down 10.1% Since Last Earnings Report?

Mirum Pharmaceuticals (MIRM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Mirum Pharmaceuticals and Incyte Announce Pivotal Late-Breaking Results for Zilurgisertib in Fibrodysplasia Ossificans Progressiva Accepted for Presentation at ENDO 2026

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) and Incyte (Nasdaq: INCY) today announced that pivotal Phase 2 results from the PROGRESS study evaluating zilurgisertib, an investigational ALK2 inhibitor, in patients with fibrodysplasia ossificans progressiva (FOP) will be presented at ENDO 2026, the...

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its products pipeline includes Maralixibat, Cholbam, Ctexli, Volixibat, Brelovitug, MRM-3379, and Zilurgisertib. The company was founded by Niall O'Donnel, Michael G. Grey, and Christopher Peetz in May 2018 and is headquartered in Foster City, CA.

Mirum Pharmaceuticals Inc

MIRM Stock Clocks Best Day In 4.5 Months On Liver Disease Trial Data: Retail Eyes Buyout At A Premium

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$109.70
Prev Close	$112.23
Open	$112.32
Dividend Yield	0.00%
50-Day Moving Average	$108.71
Beta	0.83
Avg. Volume	1.04M
PE Ratio	-8.25

52-Week High	$130.00
52-Week Low	$50.25
Market Capitalization	$6.84B
EPS (Annual)	-$0.4654
Price to Book	28.20
Revenue Per Employee	$1.4M

Feed

News

Sentiment

Earnings

Fundamentals

Info

MIRMMirum Pharmaceuticals Inc

Latest MIRM News